ATAI Life Sciences BV
ATAI
$7.35+0.00%
End of day · as of Sep 25, 2026, 7:00 AM ET
Mkt cap
$555.82M
EV/Sales
148.2
P/E ratio
N/A
FY2025 Revenue
$4.09M
EPS (TTM)
$-2.93
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-16142.02%
Beta
1.48
Div yield
N/A
Sector
Healthcare
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Use this ATAI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ATAI income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
ATAI Life Sciences BV (ATAI) is a biotechnology company in the Healthcare sector.
Latest cached ATAI Life Sciences BV (ATAI) revenue for Dec 31, 2025 was $4.1M. Net income was -$660.0M. Statements: https://lician.com/financials/atai
ATAI Life Sciences BV (ATAI) market capitalization is $555.8M on the latest cached snapshot.
ATAI Life Sciences BV (ATAI) cached previous close $7.35; day range $7.30 – $7.37. Session quote: https://lician.com/quote/atai
ATAI Life Sciences BV (ATAI) latest cached earnings event is "ATAI earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ATAI filing is 8-K · Sep 11, 2026. Filings: https://lician.com/sec/atai